Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Pharmacogenomics|September 25, 2013
Effect of NR3C2 genetic polymorphisms on the blood pressure response to enalapril treatmentJian-Quan Luo, Lu-Yan Wang, Fa-Zhong He, et al.
Clinical and Translational Medicine|August 4, 2023
Genetic and pharmacological inhibition of METTL3 alleviates renal fibrosis by reducing EVL m6A modification through an IGF2BP2-dependent mechanismWei-Jian Ni, Hong Zhou, Hao Lu, et al.
Pharmacogenetics and Genomics|April 19, 2014
Rs495828 polymorphism of the ABO gene is a predictor of enalapril-induced cough in Chinese patients with essential hypertensionJian-Quan Luo, Fa-Zhong He, Zhi-Ying Luo, et al.
Frontiers in Medicine|December 20, 2021
The Programmed Cell Death of Macrophages, Endothelial Cells, and Tubular Epithelial Cells in Sepsis-AKIChao Li, Wei Wang, Shuai-Shuai Xie, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 10, 2022
Protective effect of inhibiting necroptosis on gentamicin-induced nephrotoxicityBing-Feng Hu, Qian Gong, Shi-Qing Chen, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|March 27, 2021
Gypenoside XLIX protects against acute kidney injury by suppressing IGFBP7/IGF1R-mediated programmed cell death and inflammationQin Yang, Hong-Mei Zang, Tian Xing, et al.
Biochemical Pharmacology|July 6, 2020
Rutaecarpine derivative Cpd-6c alleviates acute kidney injury by targeting PDE4B, a key enzyme mediating inflammation in cisplatin nephropathyXue-Qi Liu, Juan Jin, Zeng Li, et al.
Molecules (Basel, Switzerland)|December 11, 2022
Epigallocatechin Gallate Attenuates Gentamicin-Induced Nephrotoxicity by Suppressing Apoptosis and FerroptosisLin Yue, Ya-Ru Yang, Wen-Xian Ma, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 20, 2023
Novel insights into STAT3 in renal diseasesJu-Tao Yu, Shuai Fan, Xiang-Yu Li, et al.
European Journal of Pharmacology|July 5, 2022
Targeted inhibition of TGF-β type I receptor by AZ12601011 protects against kidney fibrosisXiao-Guo Suo, Fang Wang, Chuan-Hui Xu, et al.
Pageof 4